BioPharm International
BioPharm International-07-01-2009
Volume: 22
Issue: 7
BioPharm International-06-01-2009
Volume: 22
Issue: 6
BioPharm International-06-02-2009
Volume: 2009 Supplement
Issue: 4
BioPharm International-05-01-2009
Volume: 22
Issue: 5
BioPharm International-04-01-2009
Volume: 22
Issue: 4
BioPharm International-04-02-2009
Volume: 2009 Supplement
Issue: 3
BioPharm International-03-01-2009
Volume: 22
Issue: 3
BioPharm International-03-02-2009
Volume: 2009 Supplement
Issue: 2
BioPharm International-02-01-2009
Volume: 22
Issue: 2
BioPharm International-01-02-2009
Volume: 2009 Supplement
Issue: 1
BioPharm International-01-01-2009
Volume: 22
Issue: 1
BioPharm International-12-01-2008
Volume: 21
Issue: 12
BioPharm International-11-02-2008
Volume: 2008 Supplement
Issue: 7
BioPharm International-11-01-2008
Volume: 21
Issue: 11
BioPharm International-10-02-2008
Volume: 2008 Supplement
Issue: 6
BioPharm International-10-01-2008
Volume: 21
Issue: 10
BioPharm International-09-01-2008
Volume: 21
Issue: 9
BioPharm International-08-01-2008
Volume: 21
Issue: 8
BioPharm International-07-01-2008
Volume: 21
Issue: 7
BioPharm International-06-01-2008
Volume: 21
Issue: 6
BioPharm International-06-02-2008
Volume: 2008 Supplement
Issue: 5
BioPharm International-05-01-2008
Volume: 21
Issue: 5
BioPharm International-04-02-2008
Volume: 2008 Supplement
Issue: 4
BioPharm International-04-01-2008
Volume: 21
Issue: 4
BioPharm International-03-01-2008
Volume: 21
Issue: 3
BioPharm International-03-02-2008
Volume: 2008 Supplement
Issue: 3
BioPharm International-02-01-2008
Volume: 21
Issue: 2
BioPharm International-02-02-2008
Volume: 2008 Supplement
Issue: 2
BioPharm International-01-02-2008
Volume: 2008 Supplement
Issue: 1
BioPharm International-01-01-2008
Volume: 21
Issue: 1
Advertisement
Advertisement
Trending on BioPharm International
1
China Approves First Monthly Biologic for COPD
2
Ultragenyx Phase III Data Reveal Limits of Bone Density Endpoints in Rare Bone Disease
3
Insuring Novel Biologic Development Against Geopolitical Developments: Part Three of Three with Abzena
4
FUJIFILM Irvine Scientific Rebrands as FUJIFILM Biosciences
5